子宫内膜异位症和子宫肌瘤与过早死亡风险:前瞻性队列研究

The BMJ Pub Date : 2024-11-20 DOI:10.1136/bmj-2023-078797
Yi-Xin Wang, Leslie V Farland, Audrey J Gaskins, Siwen Wang, Kathryn L Terry, Kathryn M Rexrode, Janet W Rich-Edwards, Rulla Tamimi, Jorge E Chavarro, Stacey A Missmer
{"title":"子宫内膜异位症和子宫肌瘤与过早死亡风险:前瞻性队列研究","authors":"Yi-Xin Wang, Leslie V Farland, Audrey J Gaskins, Siwen Wang, Kathryn L Terry, Kathryn M Rexrode, Janet W Rich-Edwards, Rulla Tamimi, Jorge E Chavarro, Stacey A Missmer","doi":"10.1136/bmj-2023-078797","DOIUrl":null,"url":null,"abstract":"Objective To prospectively assess the effect of endometriosis and uterine fibroids on the long term risk of premature mortality (younger than 70 years). Design Prospective cohort study Setting The Nurses’ Health Study II, United States (1989-2019). Participants 110 091 women aged 25-42 years in 1989 without a history of hysterectomy before endometriosis or fibroids diagnosis, cardiovascular diseases, or cancer. Main outcome measures Hazard ratios (estimated by Cox proportional hazards models) for total and cause specific premature mortality according to laparoscopically confirmed endometriosis or ultrasound or hysterectomy confirmed uterine fibroids reported in biennial questionnaires. Results 4356 premature deaths were recorded during 2 994 354 person years of follow-up (27.2 years per person), including 1459 from cancer, 304 from cardiovascular diseases, and 90 from respiratory diseases. The crude incidence of all cause premature mortality for women with and without laparoscopically confirmed endometriosis was 2.01 and 1.40 per 1000 person years, respectively. In age adjusted models, laparoscopically confirmed endometriosis was associated with a hazard ratio of 1.19 (95% confidence interval 1.09 to 1.30) for premature death; these models were strengthened after also adjusting for potential confounders including behavioral factors (1.31, 1.20 to 1.44). Cause specific mortality analyses showed that the association was largely driven by mortality from senility and ill-defined diseases (1.80, 1.19 to 2.73), non-malignant respiratory diseases (1.95, 1.11 to 3.41), diseases of the nervous system and sense organs (2.50, 1.40 to 4.44), and malignant neoplasm of gynecological organs (2.76, 1.79 to 4.26). Ultrasound or hysterectomy confirmed uterine fibroids were not associated with all cause premature mortality (1.03, 0.95 to 1.11), but were associated with a greater risk of mortality from malignant neoplasm of gynecological organs (2.32, 1.59 to 3.40) in cause specific mortality analyses. The risk of mortality caused by cardiovascular and respiratory diseases varied according to joint categories of endometriosis and uterine fibroids, with an increased risk of all cause premature mortality among women reporting both endometriosis and uterine fibroids. Conclusion Women with a history of endometriosis and uterine fibroids might have an increased long term risk of premature mortality extending beyond their reproductive lifespan. These conditions were also associated with an increased risk of death due to gynecological cancers. Endometriosis was associated with a greater risk of non-cancer mortality. These findings highlight the importance for primary care providers to consider these gynecological disorders in their assessment of women's health. The data used in the present study will not be made publicly available, but they are accessible by contacting the research staff from NHSII at <https://www.nurseshealthstudy.org/researchers>. The analytic SAS codes are available from the corresponding author and can also be found in supporting materials.","PeriodicalId":22388,"journal":{"name":"The BMJ","volume":"179 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Endometriosis and uterine fibroids and risk of premature mortality: prospective cohort study\",\"authors\":\"Yi-Xin Wang, Leslie V Farland, Audrey J Gaskins, Siwen Wang, Kathryn L Terry, Kathryn M Rexrode, Janet W Rich-Edwards, Rulla Tamimi, Jorge E Chavarro, Stacey A Missmer\",\"doi\":\"10.1136/bmj-2023-078797\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objective To prospectively assess the effect of endometriosis and uterine fibroids on the long term risk of premature mortality (younger than 70 years). Design Prospective cohort study Setting The Nurses’ Health Study II, United States (1989-2019). Participants 110 091 women aged 25-42 years in 1989 without a history of hysterectomy before endometriosis or fibroids diagnosis, cardiovascular diseases, or cancer. Main outcome measures Hazard ratios (estimated by Cox proportional hazards models) for total and cause specific premature mortality according to laparoscopically confirmed endometriosis or ultrasound or hysterectomy confirmed uterine fibroids reported in biennial questionnaires. Results 4356 premature deaths were recorded during 2 994 354 person years of follow-up (27.2 years per person), including 1459 from cancer, 304 from cardiovascular diseases, and 90 from respiratory diseases. The crude incidence of all cause premature mortality for women with and without laparoscopically confirmed endometriosis was 2.01 and 1.40 per 1000 person years, respectively. In age adjusted models, laparoscopically confirmed endometriosis was associated with a hazard ratio of 1.19 (95% confidence interval 1.09 to 1.30) for premature death; these models were strengthened after also adjusting for potential confounders including behavioral factors (1.31, 1.20 to 1.44). Cause specific mortality analyses showed that the association was largely driven by mortality from senility and ill-defined diseases (1.80, 1.19 to 2.73), non-malignant respiratory diseases (1.95, 1.11 to 3.41), diseases of the nervous system and sense organs (2.50, 1.40 to 4.44), and malignant neoplasm of gynecological organs (2.76, 1.79 to 4.26). Ultrasound or hysterectomy confirmed uterine fibroids were not associated with all cause premature mortality (1.03, 0.95 to 1.11), but were associated with a greater risk of mortality from malignant neoplasm of gynecological organs (2.32, 1.59 to 3.40) in cause specific mortality analyses. The risk of mortality caused by cardiovascular and respiratory diseases varied according to joint categories of endometriosis and uterine fibroids, with an increased risk of all cause premature mortality among women reporting both endometriosis and uterine fibroids. Conclusion Women with a history of endometriosis and uterine fibroids might have an increased long term risk of premature mortality extending beyond their reproductive lifespan. These conditions were also associated with an increased risk of death due to gynecological cancers. Endometriosis was associated with a greater risk of non-cancer mortality. These findings highlight the importance for primary care providers to consider these gynecological disorders in their assessment of women's health. The data used in the present study will not be made publicly available, but they are accessible by contacting the research staff from NHSII at <https://www.nurseshealthstudy.org/researchers>. The analytic SAS codes are available from the corresponding author and can also be found in supporting materials.\",\"PeriodicalId\":22388,\"journal\":{\"name\":\"The BMJ\",\"volume\":\"179 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-11-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The BMJ\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/bmj-2023-078797\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The BMJ","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/bmj-2023-078797","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

目的 前瞻性评估子宫内膜异位症和子宫肌瘤对过早死亡(70 岁以下)的长期风险的影响。设计 前瞻性队列研究 设定 美国护士健康研究 II(1989-2019 年)。参与者 1989 年年龄在 25-42 岁之间的 110 091 名女性,她们在确诊子宫内膜异位症或子宫肌瘤、心血管疾病或癌症之前没有子宫切除史。主要结果指标 根据两年一次的调查问卷中报告的经腹腔镜确诊的子宫内膜异位症或超声或子宫切除术确诊的子宫肌瘤,估算总死亡率和特定原因过早死亡率的危险比(通过 Cox 比例危险模型估算)。结果 在 2 994 354 人年的随访期间,共记录了 4 356 例过早死亡病例(每人 27.2 年),其中 1 459 例死于癌症,304 例死于心血管疾病,90 例死于呼吸系统疾病。经腹腔镜证实患有子宫内膜异位症和未患有子宫内膜异位症的妇女因各种原因过早死亡的粗略发生率分别为每 1000 人年 2.01 例和 1.40 例。在年龄调整模型中,经腹腔镜确诊的子宫内膜异位症与过早死亡的危险比为 1.19(95% 置信区间为 1.09 至 1.30);在调整了包括行为因素在内的潜在混杂因素后,这些模型得到了加强(1.31,1.20 至 1.44)。针对具体病因的死亡率分析表明,这种关联主要是由衰老和定义不清的疾病(1.80,1.19 至 2.73)、非恶性呼吸系统疾病(1.95,1.11 至 3.41)、神经系统和感觉器官疾病(2.50,1.40 至 4.44)以及妇科器官恶性肿瘤(2.76,1.79 至 4.26)造成的。超声或子宫切除术证实的子宫肌瘤与所有病因导致的过早死亡无关(1.03,0.95 至 1.11),但在特定病因死亡率分析中与妇科器官恶性肿瘤导致的更大死亡风险有关(2.32,1.59 至 3.40)。心血管疾病和呼吸系统疾病导致的死亡风险因子宫内膜异位症和子宫肌瘤的联合类别而异,同时患有子宫内膜异位症和子宫肌瘤的妇女因各种原因过早死亡的风险增加。结论 有子宫内膜异位症和子宫肌瘤病史的妇女,其过早死亡的长期风险可能会增加,甚至超过其生育期。这些疾病还与妇科癌症导致的死亡风险增加有关。子宫内膜异位症与非癌症死亡风险的增加有关。这些发现强调了初级保健提供者在评估妇女健康时考虑这些妇科疾病的重要性。本研究中使用的数据不会公开,但可通过联系 NHSII 的研究人员获取,联系方式是 。分析 SAS 代码可向相应作者索取,也可在辅助材料中找到。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Endometriosis and uterine fibroids and risk of premature mortality: prospective cohort study
Objective To prospectively assess the effect of endometriosis and uterine fibroids on the long term risk of premature mortality (younger than 70 years). Design Prospective cohort study Setting The Nurses’ Health Study II, United States (1989-2019). Participants 110 091 women aged 25-42 years in 1989 without a history of hysterectomy before endometriosis or fibroids diagnosis, cardiovascular diseases, or cancer. Main outcome measures Hazard ratios (estimated by Cox proportional hazards models) for total and cause specific premature mortality according to laparoscopically confirmed endometriosis or ultrasound or hysterectomy confirmed uterine fibroids reported in biennial questionnaires. Results 4356 premature deaths were recorded during 2 994 354 person years of follow-up (27.2 years per person), including 1459 from cancer, 304 from cardiovascular diseases, and 90 from respiratory diseases. The crude incidence of all cause premature mortality for women with and without laparoscopically confirmed endometriosis was 2.01 and 1.40 per 1000 person years, respectively. In age adjusted models, laparoscopically confirmed endometriosis was associated with a hazard ratio of 1.19 (95% confidence interval 1.09 to 1.30) for premature death; these models were strengthened after also adjusting for potential confounders including behavioral factors (1.31, 1.20 to 1.44). Cause specific mortality analyses showed that the association was largely driven by mortality from senility and ill-defined diseases (1.80, 1.19 to 2.73), non-malignant respiratory diseases (1.95, 1.11 to 3.41), diseases of the nervous system and sense organs (2.50, 1.40 to 4.44), and malignant neoplasm of gynecological organs (2.76, 1.79 to 4.26). Ultrasound or hysterectomy confirmed uterine fibroids were not associated with all cause premature mortality (1.03, 0.95 to 1.11), but were associated with a greater risk of mortality from malignant neoplasm of gynecological organs (2.32, 1.59 to 3.40) in cause specific mortality analyses. The risk of mortality caused by cardiovascular and respiratory diseases varied according to joint categories of endometriosis and uterine fibroids, with an increased risk of all cause premature mortality among women reporting both endometriosis and uterine fibroids. Conclusion Women with a history of endometriosis and uterine fibroids might have an increased long term risk of premature mortality extending beyond their reproductive lifespan. These conditions were also associated with an increased risk of death due to gynecological cancers. Endometriosis was associated with a greater risk of non-cancer mortality. These findings highlight the importance for primary care providers to consider these gynecological disorders in their assessment of women's health. The data used in the present study will not be made publicly available, but they are accessible by contacting the research staff from NHSII at . The analytic SAS codes are available from the corresponding author and can also be found in supporting materials.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Partha Kar: Leng’s review of physician and anaesthesia associates is welcome—with guarded optimism Unified response is needed to tackle tuberculosis among refugees and migrants Take the lead: additional medical leadership development opportunities and resources Maurice King: physician who proposed a one child policy to combat overpopulation Helen Salisbury: If GPs aren’t formally part of the NHS, what are we?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1